GridAI Technologies Corp. (GRDX)
4.80
+0.13
(+2.78%)
USD |
NASDAQ |
Nov 06, 10:20
GridAI Technologies Enterprise Value : 41.40M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 41.40M |
| November 04, 2026 | 46.65M |
| November 03, 2026 | 42.50M |
| November 02, 2026 | 42.23M |
| October 30, 2026 | 43.40M |
| October 29, 2026 | 46.79M |
| October 28, 2026 | 48.93M |
| October 27, 2026 | 49.45M |
| October 26, 2026 | 47.48M |
| October 23, 2026 | 47.86M |
| October 22, 2026 | 47.07M |
| October 21, 2026 | 42.99M |
| October 20, 2026 | 41.12M |
| October 19, 2026 | 39.46M |
| October 16, 2026 | 38.29M |
| October 15, 2026 | 39.95M |
| October 14, 2026 | 38.50M |
| October 13, 2026 | 40.57M |
| October 12, 2026 | 41.33M |
| October 09, 2026 | 43.47M |
| October 08, 2026 | 42.30M |
| October 07, 2026 | 37.60M |
| October 06, 2026 | 37.94M |
| October 05, 2026 | 35.59M |
| October 02, 2026 | 35.45M |
| Date | Value |
|---|---|
| October 01, 2026 | 32.90M |
| September 30, 2026 | 34.57M |
| September 29, 2026 | 31.65M |
| September 28, 2026 | 33.10M |
| September 25, 2026 | 32.83M |
| September 24, 2026 | 35.45M |
| September 23, 2026 | 35.80M |
| September 22, 2026 | 36.01M |
| September 21, 2026 | 32.62M |
| September 18, 2026 | 30.61M |
| September 17, 2026 | 29.99M |
| September 16, 2026 | 29.44M |
| September 15, 2026 | 29.99M |
| September 14, 2026 | 29.65M |
| September 11, 2026 | 28.89M |
| September 10, 2026 | 29.65M |
| September 09, 2026 | 29.99M |
| September 08, 2026 | 31.24M |
| September 04, 2026 | 31.58M |
| September 03, 2026 | 29.65M |
| September 02, 2026 | 33.03M |
| September 01, 2026 | 33.86M |
| August 31, 2026 | 34.83M |
| August 28, 2026 | 36.50M |
| August 27, 2026 | 36.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.737B |
| Alnylam Pharmaceuticals, Inc. | 20.38B |
| Anika Therapeutics, Inc. | 245.53M |
| Savara, Inc. | 757.02M |
| Vericel Corp. | 2.582B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.04M |
| Revenue (Quarterly) | 0.0859M |
| Total Expenses (Quarterly) | 12.90M |
| EPS Diluted (Quarterly) | -2.010 |
| Gross Profit Margin (Quarterly) | -711.5% |
| Profit Margin (Quarterly) | -15.18K% |
| Earnings Yield | -89.67% |
| Normalized Earnings Yield | -67.30 |